A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Autor: Khyatiben, Rana, Jessica, Reid, Joshua N, Rosenwasser, Todd, Lewis, Mae, Sheikh-Ali, Rushab R, Choksi, Rebecca F, Goldfaden

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Diabetes is a significant and independent risk factor for atherosclerotic cardiovascular disease (ASCVD), leading to morbidity and mortality among this population. The prevention of macrovascular complications, such as CVD, peripheral arterial diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::93802400281f3ad1909b29ce41cccb0f
https://pubmed.ncbi.nlm.nih.gov/31571964

A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent.

Autor: Hardy J; East Coast Institute for Research, Jacksonville, FL, USA., Niman S; East Coast Institute for Research, Jacksonville, FL, USA., Goldfaden RF; East Coast Institute for Research, Jacksonville, FL, USA. Rebecca.Goldfaden@ecirmed.com., Ashchi M; Ashchi Heart and Vascular Center, Jacksonville, FL, USA., Bisharat M; Ashchi Heart and Vascular Center, Jacksonville, FL, USA., Huston J; College of Pharmacy, University of Florida, Jacksonville, FL, USA., Hartmann H; East Coast Institute for Research, Jacksonville, FL, USA., Choksi R; East Coast Institute for Research, Jacksonville, FL, USA.

Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2022 Jan; Vol. 22 (1), pp. 47-54. Date of Electronic Publication: 2021 Sep 07.

A Review on the Efficacy and Safety of Oral Semaglutide.

Autor: Niman S; East Coast Institute for Research, LLC, 3550 University Blvd. South, Suite 101, Jacksonville, FL, 32216, USA., Hardy J; East Coast Institute for Research, LLC, 3550 University Blvd. South, Suite 101, Jacksonville, FL, 32216, USA., Goldfaden RF; East Coast Institute for Research, LLC, 3550 University Blvd. South, Suite 101, Jacksonville, FL, 32216, USA. Rebecca.Goldfaden@ecirmed.com., Reid J; East Coast Institute for Research, LLC, 3550 University Blvd. South, Suite 101, Jacksonville, FL, 32216, USA.; College of Pharmacy, University of Florida, Jacksonville, FL, USA., Sheikh-Ali M; Northeast Florida Endocrine and Diabetes Associates, Jacksonville, FL, USA., Sutton D; Northeast Florida Endocrine and Diabetes Associates, Jacksonville, FL, USA., Choksi R; East Coast Institute for Research, LLC, 3550 University Blvd. South, Suite 101, Jacksonville, FL, 32216, USA.

Publikováno v: Drugs in R&D [Drugs R D] 2021 Jun; Vol. 21 (2), pp. 133-148. Date of Electronic Publication: 2021 Mar 26.

Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.

Autor: Shah NK; East Coast Institute for Research, Jacksonville, Florida 32223, USA. niren@eastcoastresearch.net, Deeb WE, Choksi R, Epstein BJ

Publikováno v: Pharmacotherapy [Pharmacotherapy] 2012 Jan; Vol. 32 (1), pp. 80-94.

Recent changes in the landscape of combination RAS blockade.

Autor: Epstein BJ; Department of Pharmacotherapy, University of Florida, FL, USA., Smith SM, Choksi R

Publikováno v: Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2009 Nov; Vol. 7 (11), pp. 1373-84.